Masaru Ikeda

857 total citations
27 papers, 719 citations indexed

About

Masaru Ikeda is a scholar working on Molecular Biology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, Masaru Ikeda has authored 27 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 6 papers in Organic Chemistry. Recurrent topics in Masaru Ikeda's work include Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (4 papers) and biodegradable polymer synthesis and properties (3 papers). Masaru Ikeda is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Advanced Drug Delivery Systems (4 papers) and biodegradable polymer synthesis and properties (3 papers). Masaru Ikeda collaborates with scholars based in Japan, Germany and United States. Masaru Ikeda's co-authors include Junichi Okada, Makoto Miyajima, Akira Kusai, Kenji Nishimura, Yasuo Seta, Tomoyuki Watanabe, Tetsuhiko Isobe, Naoki Wakiyama, Mamoru Senna and Atsushi Kurihara and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Masaru Ikeda

26 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masaru Ikeda Japan 14 330 208 120 112 97 27 719
Philip L. Gould United Kingdom 7 194 0.6× 286 1.4× 202 1.7× 102 0.9× 114 1.2× 10 755
H.V. Maulding United States 14 302 0.9× 238 1.1× 81 0.7× 141 1.3× 108 1.1× 34 781
Ignazio Giannone Italy 8 340 1.0× 292 1.4× 74 0.6× 163 1.5× 143 1.5× 11 661
Ulrich Westedt Germany 11 391 1.2× 186 0.9× 175 1.5× 129 1.2× 96 1.0× 17 736
Naoki Wakiyama Japan 14 371 1.1× 137 0.7× 224 1.9× 154 1.4× 66 0.7× 25 709
David C. Bibby United Kingdom 11 288 0.9× 232 1.1× 49 0.4× 224 2.0× 121 1.2× 26 775
Peter Scholes United Kingdom 9 219 0.7× 221 1.1× 50 0.4× 108 1.0× 105 1.1× 11 521
Sandip B. Tiwari United States 16 509 1.5× 247 1.2× 84 0.7× 241 2.2× 127 1.3× 20 955
Rafael Barreiro-Iglesias Spain 12 312 0.9× 193 0.9× 58 0.5× 162 1.4× 86 0.9× 14 809
Jichao Kang United States 10 312 0.9× 270 1.3× 82 0.7× 214 1.9× 141 1.5× 10 689

Countries citing papers authored by Masaru Ikeda

Since Specialization
Citations

This map shows the geographic impact of Masaru Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaru Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaru Ikeda more than expected).

Fields of papers citing papers by Masaru Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaru Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaru Ikeda. The network helps show where Masaru Ikeda may publish in the future.

Co-authorship network of co-authors of Masaru Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masaru Ikeda. A scholar is included among the top collaborators of Masaru Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaru Ikeda. Masaru Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohshita, Joji, et al.. (2004). Synthesis of poly{[bis(diethynylphenyl)silylene]phenylene}s with highly heat-resistant properties and an application to conducting materials. Journal of Organometallic Chemistry. 689(9). 1540–1545. 20 indexed citations
2.
Okada, Mitsuru, et al.. (2003). Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy. Clinical and Experimental Nephrology. 7(4). 270–274. 4 indexed citations
3.
Takemura, Tsukasa, Satoshi Hino, Yuka Murata, et al.. (2002). Role of membrane-bound heparin-binding epidermal growth factor-like growth factor (HB-EGF) in renal epithelial cell branching. Kidney International. 61(6). 1968–1979. 23 indexed citations
4.
Watanabe, Tomoyuki, et al.. (2001). Stability of amorphous indomethacin compounded with silica. International Journal of Pharmaceutics. 226(1-2). 81–91. 121 indexed citations
5.
Seta, Yasuo, et al.. (2000). A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. International Journal of Pharmaceutics. 208(1-2). 61–70. 112 indexed citations
6.
Inoue, Kazuhiro, et al.. (2000). The Skin Permeation Mechanism of Ketotifen: Evaluation of Permeation Pathways and Barrier Components in the Strat Corneum. Drug Development and Industrial Pharmacy. 26(1). 45–53. 15 indexed citations
7.
Ikeda, Masaru, et al.. (2000). Molecular Cloning, Expression, and Chromosomal Localization of a Human Tubulointerstitial Nephritis Antigen. Biochemical and Biophysical Research Communications. 268(1). 225–230. 20 indexed citations
8.
Miyajima, Makoto, et al.. (1999). Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(l-lactic acid) matrix. Journal of Controlled Release. 61(3). 295–304. 78 indexed citations
9.
Miyajima, Makoto, et al.. (1999). Mechanism of drug release from poly(l-lactic acid) matrix containing acidic or neutral drugs. Journal of Controlled Release. 60(2-3). 199–209. 58 indexed citations
10.
Amano, Shigeru, Masaru Ikeda, Shuji Uemura, et al.. (1999). Mossy fiber sprouting in the dentate gyrus in a newly developed epileptic mutant, Ihara epileptic rat. Brain Research. 834(1-2). 214–218. 13 indexed citations
11.
Kurihara, Atsushi, et al.. (1998). Species Variation in Pharmacokinetics and Opsonization of Palmitoyl Rhizoxin (RS-1541) Incorporated in Lipid Emulsions. Journal of drug targeting. 5(6). 491–505. 2 indexed citations
12.
Miyajima, Makoto, et al.. (1998). Factors influencing the diffusion-controlled release of papaverine from poly (l-lactic acid) matrix. Journal of Controlled Release. 56(1-3). 85–94. 72 indexed citations
13.
Ikeda, Masaru. (1998). International research development on sport policies. Taiikugaku kenkyu (Japan Journal of Physical Education Health and Sport Sciences). 43(5-6). 225–233. 2 indexed citations
14.
Miyajima, Makoto, et al.. (1997). Effect of polymer crystallinity on papaverine release from poly (l-lactic acid) matrix. Journal of Controlled Release. 49(2-3). 207–215. 73 indexed citations
15.
Kurihara, Atsushi, et al.. (1996). Enhanced Tumor Delivery and Antitumor Activity of Palmitoyl Rhizoxin Using Stable Lipid Emulsions in Mice. Pharmaceutical Research. 13(2). 305–310. 22 indexed citations
16.
Kurihara, Atsushi, et al.. (1996). Pharmacokinetics of Highly Lipophilic Antitumor Agent Palmitoyl Rhizoxin Incorporated in Lipid Emulsions in Rats.. Biological and Pharmaceutical Bulletin. 19(2). 252–258. 24 indexed citations
17.
Kurihara, Atsushi, et al.. (1996). LIPID EMULSIONS OF PALMITOYLRHIZOXIN: EFFECTS OF COMPOSITION ON LIPOLYSIS AND BIODISTRIBUTION. Biopharmaceutics & Drug Disposition. 17(4). 331–342. 14 indexed citations
18.
Amano, Shigeru, et al.. (1995). Neuropathological study on a newly developed epileptic rat mutant with limbic‐like seizures. Psychiatry and Clinical Neurosciences. 49(3). S284–6. 7 indexed citations
19.
Ikeda, Masaru & Tsuneji Nagai. (1982). The acid-base equilibrium reaction of benzodiazepinooxazoles.. Chemical and Pharmaceutical Bulletin. 30(10). 3810–3816. 6 indexed citations
20.
Higuchi, Takeru & Masaru Ikeda. (1974). Rapidly Dissolving Forms of Digoxin: Hydroquinone Complex. Journal of Pharmaceutical Sciences. 63(5). 809–811. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026